Clinical Trials in Pittsburgh

Showing 15641-15660 of 21,047 trials

ADAPT: Addressing Depression and Pain Together

NCT01124188

The primary question addressed by this study is: Using a stepped care approach in primary care, what is the value of the combination of an antidepressant medication (Venlafaxine) and psychotherapy for seniors living with depression and chronic lower back pain when treatment with a low-dose of venlafaxine and supportive management (SM) has led to only a partial or non-response?

DepressionBack Pain

University of Pittsburgh263 participantsStarted May 2010

Pittsburgh, Pennsylvania, United States

TERMINATEDPhase 2< 1 mile

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

NCT02276560

The purpose of this research study is to determine whether giving cisplatin and nab-paclitaxel before surgery will reduce the presence of disease in certain areas of the lung at the time of surgery.

Stage IIIA Non-Small Cell Lung Cancer

UNC Lineberger Comprehensive Cancer Center1 participantsStarted Jan 2015

Tampa, Florida, United States • Atlanta, Georgia, United States • Kansas City, Kansas, United States +6 more locations

ADAPT: Addressing Depression and Pain Together

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Find Trials by Condition in Pittsburgh

Pharmacogenetic Response to Naltrexone For Alcohol Dependence

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

Ovarian Cancer Vaccine for Patients in Remission

REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Dose-Escalation Study of GSK2126458

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

ESSENTIAL Trial™ Sham Cross-over

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

BE Study of Naftifine HCL

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)